Cargando…
Tumour vascularization: sprouting angiogenesis and beyond
Tumour angiogenesis is a fast growing domain in tumour biology. Many growth factors and mechanisms have been unravelled. For almost 30 years, the sprouting of new vessels out of existing ones was considered as an exclusive way of tumour vascularisation. However, over the last years several additiona...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797856/ https://www.ncbi.nlm.nih.gov/pubmed/17717633 http://dx.doi.org/10.1007/s10555-007-9094-7 |
_version_ | 1782175683113385984 |
---|---|
author | Hillen, Femke Griffioen, Arjan W. |
author_facet | Hillen, Femke Griffioen, Arjan W. |
author_sort | Hillen, Femke |
collection | PubMed |
description | Tumour angiogenesis is a fast growing domain in tumour biology. Many growth factors and mechanisms have been unravelled. For almost 30 years, the sprouting of new vessels out of existing ones was considered as an exclusive way of tumour vascularisation. However, over the last years several additional mechanisms have been identified. With the discovery of the contribution of intussusceptive angiogenesis, recruitment of endothelial progenitor cells, vessel co-option, vasculogenic mimicry and lymphangiogenesis to tumour growth, anti-tumour targeting strategies will be more complex than initially thought. This review highlights these processes and intervention as a potential application in cancer therapy. It is concluded that future anti-vascular therapies might be most beneficial when based on multimodal anti-angiogenic, anti-vasculogenic mimicry and anti-lymphangiogenic strategies. |
format | Text |
id | pubmed-2797856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-27978562010-01-04 Tumour vascularization: sprouting angiogenesis and beyond Hillen, Femke Griffioen, Arjan W. Cancer Metastasis Rev Article Tumour angiogenesis is a fast growing domain in tumour biology. Many growth factors and mechanisms have been unravelled. For almost 30 years, the sprouting of new vessels out of existing ones was considered as an exclusive way of tumour vascularisation. However, over the last years several additional mechanisms have been identified. With the discovery of the contribution of intussusceptive angiogenesis, recruitment of endothelial progenitor cells, vessel co-option, vasculogenic mimicry and lymphangiogenesis to tumour growth, anti-tumour targeting strategies will be more complex than initially thought. This review highlights these processes and intervention as a potential application in cancer therapy. It is concluded that future anti-vascular therapies might be most beneficial when based on multimodal anti-angiogenic, anti-vasculogenic mimicry and anti-lymphangiogenic strategies. Springer US 2007-08-24 2007-12 /pmc/articles/PMC2797856/ /pubmed/17717633 http://dx.doi.org/10.1007/s10555-007-9094-7 Text en © Springer Science+Business Media, LLC 2007 |
spellingShingle | Article Hillen, Femke Griffioen, Arjan W. Tumour vascularization: sprouting angiogenesis and beyond |
title | Tumour vascularization: sprouting angiogenesis and beyond |
title_full | Tumour vascularization: sprouting angiogenesis and beyond |
title_fullStr | Tumour vascularization: sprouting angiogenesis and beyond |
title_full_unstemmed | Tumour vascularization: sprouting angiogenesis and beyond |
title_short | Tumour vascularization: sprouting angiogenesis and beyond |
title_sort | tumour vascularization: sprouting angiogenesis and beyond |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797856/ https://www.ncbi.nlm.nih.gov/pubmed/17717633 http://dx.doi.org/10.1007/s10555-007-9094-7 |
work_keys_str_mv | AT hillenfemke tumourvascularizationsproutingangiogenesisandbeyond AT griffioenarjanw tumourvascularizationsproutingangiogenesisandbeyond |